Following up on the sold-out event in 2009, we are proud to announce the 6th Annual Project & Portfolio Management in the Pharmaceutical Industry conference,that will take place in September 2010 in Milan, ITALY!

FIND OUT THE MOST EFFECTIVE STRATEGIES TO ENHANCE THE INNOVATION & STRONG PORTFOLIOS IN A CURRENT PAYER-DRIVEN & LIMITED RESOURCES ENVIRONMENT AT OUR CONFERENCE IN MILAN!

After 5 successful annuals and the industry feedback, we are bringing a well-balanced program full of real life case studies on major achievements in Project & Portfolio Management Approaches established across leading Pharma companies.

 

 

Testimonials:

"Good balance of speakers, great learning experience and excellent chairman!"
Director Research Project Management, MedImmune, UK

"Very high-quality & influential speakers."
Portfolio Director, AstraZeneca, UK

"Very practical, inspiring and high-level agenda. Very good conclusions from the chairman. "
Senior Portfolio Manager, GlaxoSmithKline, Belgium

 

Expert Advisors:
Head of Discovery Research, Roche, Switzerland
Vice President Portfolio Management, Strategic Planning, Bayer Schering Pharma, Germany
Vice President Project Management R&D, Amgen, USA
Scientific Vice President, Novo Nordisk, Denmark
Head R&D Portfolio Management, UCB, UK
Executive Vice President & Chief Scientific Officer, Ipsen, France
Executive Vice President Research & Development, Nycomed, Germany

 

Vice President Special Operations, Worldwide Research Centers of Emphasis, Pfizer, UK
Global Head Portfolio Management & Reporting, Sanofi Aventis, France
Head Global Project Management, Abbott, Germany
Global Head of Portfolio Management & Interfaces Discovery Research and Oncology, MerckSerono, Switzerland
Head Portfolio Management, Bayer Schering Pharma, Germany
Vice President Research, Lundbeck, Denmark
Senior Project Leader Cancer Immunotherapeutics, GSK Biologicals, Belgium

• Explore the ways how leading Pharma companies develop their portfolios to add value to key stakeholders
• Trends in portfolio offerings – more for physicians, payers or patients?
• The impact of current payer-driven environment and cost-containment initiatives on managing R&D projects
• Achieving a balanced, rich & varied portfolio in a competitive and limited resources environment
• Innovative approaches to managing Discovery Projects
• Project Management in Late stage Development Projects
• Prioritization and decision analysis tools –decision making on innovation
• Balancing the risks in Project & Portfolio Management - Risk Management in PPM
• Enhancing the innovation & strong portfolios through R&D collaborations and M&A – the role of alliance management & business development
  
  

Vice Presidents, Heads, Directors, Senior Managers and Managers of: Portfolio Management, Project Management, Pharmaceutical Development, R&D, Strategic Planning & Decision, Strategy & Portfolio Analysis, Portfolio Selection, Decision Analysis

OUR PAST ATTENDEES
AstraZeneca | Amgen | Actelion | Bristol Myers Squibb | Baxter | Bayer | Schering Pharma | Boehringer Ingelheim | Celgene | Debiopharm | Ferring | Galapagos | Galderma | Genzyme | GlaxoSmithKline | Lundbeck | MedImmune | Merck Serono | Merck & Co | Merz Pharmaceuticals | Novo Nordisk | Novartis | Nycomed | Orion | Roche | Pfizer | Sandoz | Sanofi Aventis | Solvay | Wyeth | Almirall | Eli Lilly | Esteve | Nobel | Polpharma | UCB | Abbott | Teva | LEO Pharma